Intercept Pharmaceuticals Inc
NASDAQ:ICPT
Intercept Pharmaceuticals Inc
Total Other Income
Intercept Pharmaceuticals Inc
Total Other Income Peer Comparison
Competitive Total Other Income Analysis
Latest Figures & CAGR of Competitors
Company | Total Other Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Intercept Pharmaceuticals Inc
NASDAQ:ICPT
|
Total Other Income
$14.2m
|
CAGR 3-Years
30%
|
CAGR 5-Years
18%
|
CAGR 10-Years
54%
|
|
Abbvie Inc
NYSE:ABBV
|
Total Other Income
-$4.7B
|
CAGR 3-Years
6%
|
CAGR 5-Years
-204%
|
CAGR 10-Years
N/A
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Total Other Income
$252m
|
CAGR 3-Years
22%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
N/A
|
|
Amgen Inc
NASDAQ:AMGN
|
Total Other Income
$151m
|
CAGR 3-Years
126%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Total Other Income
-$15.3m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-61%
|
CAGR 10-Years
N/A
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Total Other Income
-$31.6m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Intercept Pharmaceuticals Inc's Total Other Income?
Total Other Income
14.2m
USD
Based on the financial report for Sep 30, 2023, Intercept Pharmaceuticals Inc's Total Other Income amounts to 14.2m USD.
What is Intercept Pharmaceuticals Inc's Total Other Income growth rate?
Total Other Income CAGR 10Y
54%
Over the last year, the Total Other Income growth was 520%. The average annual Total Other Income growth rates for Intercept Pharmaceuticals Inc have been 30% over the past three years , 18% over the past five years , and 54% over the past ten years .